Lingdolinurad lowers the incidence of acute gout flares in phase 2b studies—an advantage that remains challenging for existing gout therapies.

The UK's National Institute for Health and Clinical Excellence (NICE) has published final guidance  declining to recommend pegloticase (Krystexxa), within its marketing authorization, for ...

For gout patients with large effusions, arthrocentesis followed by IA steroids will relieve the discomfort of the effusion and provide rapid pain relief. • Opioids: Opioids have no primary role in the ...

Asymptomatic hyperuricemia Acute/intermittent gout Advanced gout (or what used to be called chronic tophaceous gout). The rate of progression from asymptomatic hyperuricemia to advanced gout varies ...

October 2, 2012 — New gout guidelines from the American College of Rheumatology are meant to improve gout management by providing clinicians with clear, readily implemented guidance on urate-lowering ...

JIANGSU, China--(BUSINESS WIRE)--Atom Bioscience (Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.), a clinical stage biotechnology company developing new treatments for inflammatory and metabolic ...

Mr. F has a 5-year history of hypertension, for which he has been receiving hydrochlorothiazide. He was on a low-sodium diet. He has also suffered from nephrolithiasis with several calcium oxalate ...

Management of a patient allergic to allopurinol can be considered a therapeutic challenge. This article highlights the diversity of medications that can be used to manage hyperuricemia during this ...

Xanthine oxidase inhibitors, primarily allopurinol and febuxostat, are the mainstay of treatment. The goal of chronic gout management includes lowering serum urate levels to below 6 mg/dL. 5 Overall, ...

When you think of arthritis, achy, warm, swollen joints probably come to mind. These are indeed some of the most common symptoms of arthritis. But did you know there are actually over 100 different ...